Entries of Ganser, A. on the publication server

Schlenk, R. F., Weber, D., Herr, W., Wulf, G., Salih, H. R., Derigs, H. G., Kuendgen, A., Ringhoffer, M., Hertenstein, B., Martens, U. M., Grießhammer, M., Bernhard, H., Krauter, J., Girschikofsky, M., Wolf, D., Lange, E., Westermann, J., Koller, E., Kremers, S., Wattad, M., Heuser, M., Thol, F., Göhring, G., Haase, D., Teleanu, V., Gaidzik, V., Benner, A., Döhner, K., Ganser, A., Paschka, P. and Döhner, H. (2019) Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine. Leukemia 33 (8), pp. 1923-1933. Fulltext not available.

Weissinger, E. M., Human, C., Metzger, J. , Hambach, L., Wolf, D., Greinix, H. T., Dickinson, A. M., Mullen, W., Jonigk, D., Kuzmina, Z., Kreipe, H., Schweier, P., Böhm, O., Türüchanow, I., Ihlenburg-Schwarz, D., Raad, J., Durban, A., Schiemann, M., Könecke, C., Diedrich, H., Holler, E., Beutel, G., Krauter, J., Ganser, A. and Stadler, M. (2017) The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation. Leukemia 31 (3), pp. 654-662. Fulltext not available.

Gratwohl, A., Pfirrmann, M., Zander, A., Kröger, N., Beelen, D., Novotny, J., Nerl, C., Scheid, C., Spiekermann, K., Mayer, J., Sayer, H. G., Falge, C., Bunjes, D., Döhner, H., Ganser, A., Schmidt-Wolf, I., Schwerdtfeger, R., Baurmann, H., Kuse, R., Schmitz, N., Wehmeier, A., Fischer, J. Th., Ho, A. D., Wilhelm, M., Goebeler, M.-E., Lindemann, H. W., Bormann, M., Hertenstein, B., Schlimok, G., Baerlocher, G. M., Aul, C., Pfreundschuh, M., Fabian, M., Staib, P., Edinger, M. , Schatz, M., Fauser, A., Arnold, R., Kindler, T., Wulf, G., Rosselet, A., Hellmann, A., Schäfer, E., Prümmer, O., Schenk, M., Hasford, J., Heimpel, H., Hossfeld, D. K., Kolb, H.-J., Büsche, G., Haferlach, C., Schnittger, S., Müller, M. C., Reiter, A., Berger, U., Saußele, S., Hochhaus, A. and Hehlmann, R. (2016) Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia 30 (3), pp. 562-569. Fulltext not available.